Thioredoxins function as deglutathionylase enzymes in the yeast Saccharomyces cerevisiae by Greetham, Darren et al.
RESEARCH ARTICLE Open Access
Thioredoxins function as deglutathionylase
enzymes in the yeast Saccharomyces cerevisiae
Darren Greetham
1, Jill Vickerstaff
1, Daniel Shenton
1, Gabriel G Perrone
1,2, Ian W Dawes
1,2, Chris M Grant
1*
Abstract
Background: Protein-SH groups are amongst the most easily oxidized residues in proteins, but irreversible
oxidation can be prevented by protein glutathionylation, in which protein-SH groups form mixed disulphides with
glutathione. Glutaredoxins and thioredoxins are key oxidoreductases which have been implicated in regulating
glutathionylation/deglutathionylation in diverse organisms. Glutaredoxins have been proposed to be the
predominant deglutathionylase enzymes in many plant and mammalian species, whereas, thioredoxins have
generally been thought to be relatively inefficient in deglutathionylation.
Results: We show here that the levels of glutathionylated proteins in yeast are regulated in parallel with the
growth cycle, and are maximal during stationary phase growth. This increase in glutathionylation is not a response
to increased reactive oxygen species generated from the shift to respiratory metabolism, but appears to be a
general response to starvation conditions. Our data indicate that glutathionylation levels are constitutively high in
all growth phases in thioredoxin mutants and are unaffected in glutaredoxin mutants. We have confirmed that
thioredoxins, but not glutaredoxins, catalyse deglutathionylation of model glutathionylated substrates using
purified thioredoxin and glutaredoxin proteins. Furthermore, we show that the deglutathionylase activity of
thioredoxins is required to reduce the high levels of glutathionylation in stationary phase cells, which occurs as
cells exit stationary phase and resume vegetative growth.
Conclusions: There is increasing evidence that the thioredoxin and glutathione redox systems have overlapping
functions and these present data indicate that the thioredoxin system plays a key role in regulating the
modification of proteins by the glutathione system.
Background
All aerobic organisms are exposed to reactive oxygen
species (ROS) during the course of normal aerobic
metabolism or following exposure to radical-generating
compounds. Such ROS cause wide-ranging damage to
macromolecules, resulting in genetic degeneration and
physiological dysfunction, leading eventually to cell
death. Cysteine residues are one of the most easily oxi-
dized residues in proteins, and oxidation can result in
intermolecular protein cross-linking and enzyme inacti-
vation. However, such irreversible oxidation events can
be prevented by protein S-thiolation, in which protein
-SH groups form mixed disulphides with low molecular
weight thiol compounds [1,2].
Glutathionylation is the major form of S-thiolation in
eukaryotic cells. This reversible post-translational modi-
fication involves the formation of a mixed disulphide
between a free thiol on a protein and a molecule of glu-
tathione (GSH) (Fig. 1). It is particularly important since
it can both protect cysteine residues from irreversible
oxidation and can also regulate the activity of many tar-
get proteins. Greater than 150 targets of modification
have been identified from eukaryotic species affecting
diverse processes including glycolysis, protein synthesis,
protein degradation, signal transduction and transport
[3,4]. In many cases, this protein modification is impli-
cated in the regulation of protein function and activity;
examples include the HIV-1 protease [5], ubiquitin-
conjugating enzymes in bovine retina cells [6], DNA
binding by the transcription factor c-Jun [7] and the
glycolytic enzyme glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) [8]. Protein glutathionylation is a
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conditions, as well as following exposure to an oxidative
stress. Models have been proposed in which this protein
modification does not require an enzymatic activity, but
proceeds via the reaction of partially oxidised protein
sulphydryls with GSH, or by thiol/disulphide exchange
reactions with the oxidised disulphide form of glu-
tathione (Fig. 1) [9]. There does not appear to be any
unifying feature of target proteins, and the fact that not
all -SH containing proteins are modified in response to
a no x i d a t i v es t r e s ss u g g e s t st h a tt h i sp r o t e i nm o d i f i c a -
tion must be tightly regulated [10,11].
To protect protein-SH groups against irreversible
oxidation, or to serve a regulatory function, glutathiony-
lation must be reversible. Many studies have demon-
strated that modified proteins formed during oxidative
stress are readily deglutathionylated once the stress is
removed, but the physiological electron donors are
unclear. Three main classes of enzyme have been impli-
cated in this reaction, namely sulphiredoxin, glutaredox-
ins and thioredoxins [9]. Sulphiredoxin is an
oxidoreductase which was originally identified based on
its ability to reduce cysteine sulphinic acid in 2-Cys per-
oxiredoxins. The human enzyme has been proposed to
act as a deglutathionylating enzyme [12], although the
specificity of this reaction has been questioned [9]. Glu-
taredoxins and thioredoxins were originally identified as
hydrogen donors for ribonucleotide reductase, but also
act upon a number of metabolic enzymes that form a
disulphide as part of their catalytic cycle. They are
structurally similar and have been conserved throughout
evolution. Despite considerable functional overlap, they
are differentially regulated. The oxidised disulphide form
of thioredoxin is reduced directly by NADPH and thior-
edoxin reductase, whereas, glutaredoxin is reduced by
glutathione (GSH) using electrons donated by NADPH.
Glutaredoxins appear to be the most efficient deglu-
tathionylase enzymes based on in vitro experiments. For
example, a correlation has been demonstrated between
protein-SSG reduction and glutaredoxin activity in
mammalian cells [13]. Additionally, mammalian mito-
chondrial glutaredoxin 2 has been implicated in protein
glutathionylation, catalysing the formation of protein
mixed disulphides with glutathione [14]. Thioredoxins
have also been implicated in deglutathionylation in
in vitro experiments, but the physiological relevance of
this reaction is unclear [4,15].
Yeast, like most eukaryotes, contains a complete cyto-
plasmic thioredoxin system, comprising two thioredox-
ins (TRX1-2) and a thioredoxin reductase (TRR1), which
functions in protection against oxidative stress [reviewed
in [16]]. Trx1 and Trx2 are active as antioxidants and
play key roles in protection against oxidative stress
induced by various ROS [17]. Two yeast genes encode
classical glutaredoxins (GRX1 and GRX2). Grx1 and
Grx2 are active as GSH-dependent oxidoreductases, but
appear to have distinct cellular functions [18,19]. Dithiol
glutaredoxins have been proposed to be the predomi-
nant deglutathionylase enzymes in many organisms as
described above. However, we have previously shown
that the global levels of protein S-thiolation are unaf-
fected in yeast mutants lacking glutaredoxins (GRX1
and GRX2) and are elevated in mutants lacking thiore-
doxins (TRX1 and TRX2) [17,18]. In this current study
we have examined the roles of glutaredoxins and thiore-
doxins in the control of glutathionylation. Our data
show that thioredoxins, but not glutaredoxins, are
required to maintain glutathionylation levels during the
yeast growth cycle. Furthermore, we show that thiore-
doxins, but not glutaredoxins, are active in the deglu-
tathionylation of model mixed disulphide substrates
in vitro. The deglutathionylase activity of thioredoxins
appears to be particularly required in stationary phase
cells and we propose that thioredoxins function to
reduce glutathionylated-proteins as cells exit stationary
phase and resume vegetative growth.
Results
Glutathionylation is growth phase regulated in yeast
Yeast cells grow by fermentation on glucose-based
media, until the glucose is exhausted; they then shift to
growth by respiration using ethanol generated from gly-
colysis. The diauxic shift occurs when cells exhaust the
glucose and there is a transient growth lag as they
switch from fermentation to growth by respiration. Cells
then arrest growth and enter stationary phase when
there is no longer any net increase in cell number. Yeast
cell growth was followed on minimal media (Fig. 2A)
and glutathione levels measured. Glutathionylated-pro-
tein (GSSP) levels were found to be lowest during expo-
nential phase growth, and increased as cells progressed
through the diauxic shift and entered stationary phase
Figure 1 Modification of proteins by glutathionylation.T h i s
reversible post-translational modification involves the formation of a
mixed disulphide between a free thiol group on a protein and a
molecule of glutathione. This may occur through oxidation of a
protein-thiol group in response to ROS, and reaction with GSH as
shown in the diagram. Alternatively, oxidized GSSG may react with
protein-SH groups (for a review, see [9]). Deglutathionylation may
be catalysed by glutaredoxin (Grx) or thioredoxin (Trx).
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revealed that reduced GSH similarly increases in parallel
with growth, reaching maximal levels during stationary
phase (Fig. 2C). In contrast, oxidized GSSG levels were
relatively unaffected in response to growth phase. These
data indicate that the increase in GSSP levels observed
during the growth cycle does not simply arise in
response to a shift in the glutathione redox balance to a
more oxidized state.
The intracellular signal for increased glutathionylation
may arise due to the shift to respiratory growth condi-
tions which would be expected to generate ROS via the
mitochondrial electron transport chain. To test whether
respiratory growth conditions affect glutathionylation,
GSSP levels were measured in an isogenic petite [rho
0]
mutant which is unable to grow by respiration (Fig. 3).
A stationary phase increase in glutathionylation was still
observed in this mutant indicating that the shift to
respiratory growth does not account for increased glu-
tathionylation. To test directly whether respiratory
growth elevates glutathionylation, GSSP levels were
examined in exponential phase cells grown on a respira-
tory carbon source (glycerol and ethanol). GSSP levels
were moderately elevated by approximately two-fold
under respiratory conditions, but were still significantly
lower than that observed in stationary phase cells (Fig. 3).
Similarly, rapidly shifting cells from a fermentative to a
respiratory carbon source did not increase glutathionyla-
tion to stationary phase levels (data not shown). Since
stationary phase occurs when cells exhaust essential
nutrients, we tested whether glutathionylation is
increased in response to carbon or nitrogen starvation.
Cells were grown to exponential phase and shifted to
media lacking glucose or a nitrogen source for four
hours. In both cases, GSSP levels were elevated with
a more pronounced five-fold induction observed in
response to nitrogen starvation (Fig. 3). Similar to the
growth phase regulation of GSSP levels, total glutathione
levels were also increased in response to nutrient starva-
tion. Thus, the increase in stationary phase glutathionyla-
tion appears to predominantly be a response to
starvation conditions.
Glutathionylation is constitutively high in thioredoxin
mutants
The low levels of glutathionylation observed during
exponential phase growth may simply arise due to the
lack of any signal to elevate GSSP levels, or alternatively,
GSSP levels may by kept low by an enzymatic activity.
As described in the Introduction, glutaredoxins have
been proposed to be the predominant deglutathionylase
enzymes in many systems. We therefore examined the
growth phase-dependent regulation of glutathionylation
in mutants lacking glutaredoxins. GSSP levels in a glu-
taredoxin mutant (grx1 grx2) were comparable to the
wild-type control strain, and displayed a similar station-
ary phase increase (Fig. 4). In contrast, analysis of GSSP
levels in a thioredoxin mutant (trx1 trx2) revealed that
they are constitutively high during both exponential and
stationary growth phases (Fig. 4). Similarly, total glu-
tathione levels were elevated in the trx1 trx2 mutant
consistent with the known constitutive activation of the
Yap1 transcription factor which induces the expression
of a number of antioxidants including glutathione bio-
synthetic enzymes in thioredoxin mutants [20]. These
data indicate that thioredoxins appear to be required to
maintain low levels of GSSP during exponential growth.
Figure 2 Glutathionylation is growth phase regulated in yeast. (A) The wild-type strain was grown in minimal SD media and growth
monitored by following A600. (B) Protein bound (GSSP), reduced (GSH) (C), and oxidized (GSSG) (C) glutathione levels were quantified at
intervals as indicated. Values shown are the means of at least three independent determinations and are given in nmol/ml/A600.
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and thioredoxins in protein glutathionylation, we exam-
ined whether their overexpression alters GSSP levels
(Fig. 5). Multi-copy vectors were used to overexpress
the thioredoxin (TRX1, TRR1)o rg l u t a r e d o x i n( GRX1,
GLR1)s y s t e m s .W eh a v ep r e v i o u s l yu s e dt h e s ev e c t o r s
to confirm that overexpression of GRX1 and TRX1 con-
fers resistance to hydrogen peroxide [17]. Overexpres-
sion of the thioredoxin system did not significantly
affect the levels of oxidized (GSSG) or reduced (GSH)
glutathione (Fig. 5). In agreement with the idea that
thioredoxins maintain low exponential phase GSSP
levels, overexpression of the thioredoxin system was
found to decreases GSSP levels by approximately 50%.
In contrast, overexpression of the glutaredoxin system
resulted in an approximate 66% increases in GSSP
levels, confirming that glutaredoxins do not act as gen-
eral deglutathionylases in vivo.G S Hl e v e l sw e r eu n a f -
fected, whereas, GSSG levels were significantly lowered
by the glutaredoxin system presumably due to the
activity of Glr1. These data further confirm that there
does not appear to be any strong correlation between
cellular GSSP and GSSG levels.
Thioredoxins, but not glutaredoxins, are active as
deglutathionylases
Thioredoxin and glutaredoxin system components were
purified to confirm their roles in deglutathionylation.
Well-established glutaredoxin and thioredoxin-depen-
dent assays were first used to confirm that the purified
proteins were active. The oxidoreductase activity of glu-
taredoxins has been extensively characterized by their
ability to reduce the mixed disulphide formed between
GSH and HED [21]. In this reaction, glutaredoxins
reduce the GSH-HED mixed disulphide and the reaction
rate is followed by the oxidation of NADPH by glu-
tathione reductase. Purified Grx1 was active in this
assay confirming GSH-dependent oxidoreductase activ-
ity (Fig. 6A). Thioredoxins were also tested in this assay
Figure 4 Thioredoxins are required to maintain low levels of
glutathionylation during exponential phase growth. The wild-
type, glutaredoxin (grx1 grx2) and thioredoxin (trx1 trx2) mutant
strains were grown to exponential (Exp) or stationary (Stat) phase in
minimal SD media. Total (GSH) and protein bound (GSSP) glutathione
levels were determined. Values shown are the means of at least three
independent determinations and are given in nmol/ml/A600.
Figure 3 Increased stationary phase glutathionylation is a
starvation response. Wild-type and petite mutant strains were
grown to exponential (Exp) or stationary (Stat) phase in minimal
SD media. The effect of respiratory growth (Resp) was
determined by growing the wild-type strain to exponential phase
on minimal media containing glycerol and ethanol as carbon
sources. Carbon (-C) and nitrogen (-N) starvations were induced
by growing the wild-type strain in SD media to exponential
phase and shifting cells to fresh media lacking a carbon or
nitrogen source, respectively. Total (GSH) and protein bound
(GSSP) glutathione levels were determined. Values shown are the
means of at least three independent determinations and are
given in nmol/ml/A600.
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Trr1, respectively. The yeast thioredoxins were active in
this assay, albeit with reduced activity compared to
Grx1. Interestingly, Trx2 was more active than Trx1
suggesting a difference in the mixed disulphide oxidore-
ductase activities of the yeast thioredoxin isoenzymes.
The protein disulphide reductase activity of thioredoxins
is often measured using insulin as a substrate [22]. In
this reaction, thioredoxins reduce disulphide bonds in
insulin and the reaction is followed by the oxidation of
NADPH by thioredoxin reductase. Trx1 and Trx2 were
both active in this assay and displayed similar reaction
rates (Fig. 6A). In contrast, no reactivity was found with
Grx1 (in a reaction containing Glr1 and GSH) indicating
that Grx1 is unable to reduce protein disulphides.
Figure 5 Overexpression of the thioredoxin system reduces
glutathionylation. The wild-type strain containing pRS426 (v),
thioredoxin system (Trx1 and Trr1) or glutaredoxin system (Grx1 and
Glr1) was grown to exponential phase in minimal SD media. Reduced
(GSH), oxidized (GSSG) and protein bound (GSSP) glutathione levels
were determined. Values shown are the means of at least three
independent determinations and are given in nmol/ml/A600.
Figure 6 Thioredoxins reduce glutathionylated proteins in
vitro. (A) Thioredoxin and glutaredoxin activities for purified proteins
were determined using standard enzyme assays. Oxidoreductase
activity was measured by the ability to reduce the mixed disulphide
formed between GSH and HED. The reaction rate for Grx1 was
followed by the oxidation of NADPH by glutathione reductase.
Thioredoxins were tested in this assay by substituting Grx1 and Glr1,
with Trx1 or Trx2 and Trr1, respectively. Protein disulphide reductase
activity was measured using insulin as a substrate. The reduction of
disulphide bonds in insulin was followed by the oxidation of NADPH
by thioredoxin reductase (Trx1 and Trx2) or glutathione reductase
(Grx1). Reaction rates are given as μmoles of NADPH oxidized per
minute (×10
-3) and represent the means of at least three
independent determinations. (B) MALDI-TOF analysis of
glutathionylated creatine kinase. The ion at 2871.2 m/z corresponds
to the peptide containing the active site cysteine residue (control).
Incubation with a 10-fold molar excess of GSSG (+GSSG) resulted in a
new peak with a mass shift of 305 Da (3176.4 m/z) consistent with
the addition of a glutathione molecule. Thioredoxins (Trx1 or Trx2)
can reduce glutathionylated creatine kinase and the modified
peptide was shifted to the unmodified form. In contrast,
glutaredoxins (Grx1 or Grx2) did not display deglutathionylase activity
and the glutathionylated peptide was still detected (3176.4 m/z).
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two model glutathionylated substrates. Creatine kinase
is a well characterized enzyme which can undergo glu-
tathionylation at its active site cysteine residue [23]. We
incubated rabbit creatine kinase with a ten-fold molar
excess of oxidized GSSG and examined glutathionylation
by tryptic digestion and MALDI-TOF-MS analysis
(Fig. 6B). The tryptic peptide encompassing the active
site (2871 m/z) was found to show a mass increase of
3 0 5D a( 3 1 7 6 . 4m / z )c o n s i s t e n tw i t has i n g l em o d i f i c a -
tion by glutathionylation. Incubation with the glutare-
doxin system (Grx1 or Grx2, GSH, Glr1) did not affect
the glutathionylated peptide. In contrast, both Trx1 and
Trx2 were able to reduce the glutathionylated peptide to
the non-modified form. To confirm that the reactivity of
the thioredoxin system is not confined to creatine
kinase, deglutathionylase activity was also tested with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
which has frequently been identified as a target of
glutathionylation in various cellular systems [24].
Glutathionylation of the active site Cys residue of
GAPDH was similarly detected by tryptic digestion and
MALDI-TOF-MS analysis (data not shown). The thiore-
doxin system (Trx1 or Trx2) was able to reduce glu-
t a t h i o n y l a t e dG A P D H ,w h e r e a s ,n og l u t a t h i o n y l a s e
activity was detected with the glutaredoxin system.
These data confirm that yeast cytoplasmic thioredoxins,
but not glutaredoxins, are active in deglutathionylation.
Thioredoxin mutants are delayed in the transition from
stationary phase to exponential phase growth
Given that protein glutathionylation was found to be
maximal during stationary phase, we reasoned that
deglutathionylation must occur when cells exit stationary
phase and re-enter exponential phase growth. We there-
fore examined glutathionylation in stationary phase cells,
following inoculation into fresh media, containing all the
necessary nutrients to resume growth. The high levels of
stationary phase glutathionylation were reduced within
two hours in a wild-type strain (Fig. 7A). In contrast, glu-
tathionylation was constitutively high in a thioredoxin
mutant confirming that thioredoxins are required for
deglutathionylation. To test whether the lack of deglu-
tathionylation activity affects the resumption of growth
in stationary phase cells, we compared the growth cycle
of wild-type and thioredoxin mutants. Cells were inocu-
lated from stationary phase cultures into fresh media, at
identical starting cell densities (A600 = 0.2). This analysis
demonstrated that there is a longer lag phase in thiore-
doxin mutants which take approximately 11 hours to
enter exponential growth, compared with eight hours in
the wild-type control strain (Fig. 7B). Once exponential
phase resumed, the thioredoxin mutant was relatively
unaffected and displayed a similar doubling time to the
wild-type strain.
Discussion
Yeast, like most eukaryotes, contains a complete cyto-
plasmic thioredoxin system, which functions in protec-
tion against oxidative stress. Trx1 and Trx2 are active as
antioxidants and play key roles in protection against oxi-
dative stress induced by various ROS [17]. Grx1 and
Grx2 are active as GSH-dependent oxidoreductases, but
appear to have distinct cellular functions [18,19]. Five
monothiol glutaredoxins have also now been identified
in yeast, differing from classical glutaredoxins in that
they contain a single cysteine residue at their putative
active sites. They are found in different subcellular com-
partments including nuclear (Grx3-4), the mitochondrial
matrix (Grx5) and the early secretory pathway (Grx6-7)
[25-27]. Grx5 has been proposed to play a role in pro-
tein glutathionylation and is required for deglutathiony-
lation of cytosolic GAPDH [28]. However, grx5 mutants
are defective in the assembly of Fe/S enzymes and the
mitochondrial localization of Grx5 means that any effect
on deglutathionylation is most likely indirect caused by
the alteration in cellular iron levels [29].
Glutaredoxins have been proposed to be the predomi-
nant deglutathionylase enzymes in many eukaryotic sys-
tems. However, analysis of GSSP levels in yeast
glutaredoxin mutants (grx1 grx2) revealed that they are
comparable to the wild-type control strain. Additionally,
we found that glutaredoxins were unable to reduce
model glutathionylated proteins in vitro.I ti ss u r p r i s i n g
that the yeast glutaredoxins do not appear to influence
protein glutathionylation since this is one of the main
activities described for these enzymes in many mamma-
lian and plant systems. For example, in vitro compari-
sons using glutathionylated substrates revealed that
glutaredoxin, thioredoxin, protein disulphide isomerase,
glutathione, and cysteine all display deglutathionylation
activity, but glutaredoxin was found to be the most effi-
cient deglutathionylase enzyme [15,30]. In addition, a
correlation between protein-SSG reduction and glutare-
doxin activity has been demonstrated in mammalian
cells [13] and the reversible S-glutathiolation of HIV-1
protease can be catalysed by a glutaredoxin in vitro [5].
Grx1-knockout mice have been constructed and are
deficient in deglutathionylase activity, but were surpris-
ingly unaffected in sensitivity to oxidative insults [31].
Perhaps the most compelling evidence for a role of
human Grx1 in deglutathionylation has come from stu-
dies where altered levels of Grx1 have been shown to
regulate glutathionylation of several specific target pro-
teins including Ras, inhibitory kappa B kinase, actin and
caspase 3 [32-35]. We cannot at this stage rule out that
the yeast glutaredoxins are required for deglutathionyla-
tion of specific target proteins which would not be
detectable in our analysis of global modification levels.
Interestingly, mammalian mitochondrial glutaredoxin 2
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ing the formation of protein mixed disulphides with glu-
tathione [14]. We similarly observed that overexpression
of yeast Grx1 elevates global protein glutathionylation
levels. This did not arise due to a shift to a more oxidiz-
ing environment since oxidized GSSG concentrations
were lowered in parallel with the increase in glutathio-
nylation. Further work will be required to determine
whether yeast glutaredoxins catalyse glutathionylation of
specific target proteins.
Unlike in glutaredoxin mutants, high levels of glu-
tathionylation were detected in thioredoxin mutants
(trx1 trx2). Purified thioredoxins were also found to cat-
alyse deglutathionylation of model substrate proteins.
The requirement for yeast thioredoxins to maintain pro-
tein glutathionylation levels is in contrast to thioredox-
ins from other eukaryotic species which are generally
thought to be inefficient in deglutathionylation [4,15,36].
The low levels of glutathionylation detected during
exponential phase growth could be further reduced by
Figure 7 Thioredoxins reduce glutathionylated proteins as cells resume exponential phase from stationary phase growth.
(A) Thioredoxins are required to reduce glutathionylation during the transition from stationary phase to exponential phase growth. Stationary
phase cells of the wild-type and thioredoxin mutant strains were inoculated into fresh SD media and protein bound (GSSP) glutathione levels
determined after two hours growth. Values shown are the means of at least three independent determinations and are given in nmol/ml/A600.
(B) Thioredoxin mutants are delayed in the exit from stationary phase. Stationary phase cells of the wild-type and thioredoxin mutant strains
were inoculated into fresh SD media and growth monitored by following A600.
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Page 7 of 10overexpression of the thioredoxin system indicating that
this protein modification is constitutively present on at
l e a s ts o m et a r g e tp r o t e i n s .W ef o u n dt h a tp r o t e i ng l u -
tathionylation levels peak in wild-type cells as they exit
exponential phase and enter stationary phase growth. In
contrast, glutathionylation was constitutively high during
all growth phases in thioredoxin mutants. Our data indi-
cate that thioredoxin activity appears to be required to
reduce the high levels of stationary phase glutathionyla-
t i o na sc e l l se x i tt h i sg r o w t hp h a s ea n dr e s u m ee x p o -
nential phase growth. This requirement for thioredoxins
correlates with the increased expression of TRX1 and
TRX2 which is observed in stationary phase cells [17].
Glutathionylation has been proposed to serve a pro-
tective function which prevents the irreversible oxida-
tion of cysteine residues during oxidative stress
conditions. However, our data indicate that the station-
ary phase increase in glutathionylation is unlikely to
a r i s ed u et oas i m p l ei n c r e a s ei nR O Sg e n e r a t e db y
respiratory growth since glutathionylation was only
modestly increased in cells grown on a respiratory car-
bon source and was unaffected in respiratory deficient
cells. Additionally, little or no increase in oxidized
GSSG was detected indicating that glutathionylation
does not correlate with a shift in the glutathione redox
couple to a more oxidized state. Glutathionylation was
significantly increased in response to starvation for car-
bon or nitrogen which may indicate that this protein
modification is a general response to starvation condi-
tions. The increase in glutathionylation was coincident
with maximal levels of cellular glutathione which are
detected as cells exit stationary phase [37]. This may
suggest that protein-bound glutathione serves as a store
which can be rapidly mobilized when cells resume active
growth. This idea is supported by the observation that
there appears to be a correlation between the levels of
reduced GSH and GSSP, which are increased in parallel
in thioredoxin mutants and in response to starvation
conditions. GSSP levels may therefore reflect an in
increase in the reactants of glutathionylation, rather
than a physiologically controlled process. However, the
finding that overexpression of the glutaredoxin system
elevates GSSP levels without altering GSH levels, argues
against this idea since increased glutathionylation is
observed in the absence of increased GSH levels. An
alternative possibility is that glutathionylation may serve
ar e g u l a t o r yr o l ew h i c ha l t e r st h ea c t i v i t ya n d / o rs t r u c -
ture of cysteine-containing proteins. For example, glu-
tathionylation inhibits the activity of a number of
glycolytic enzymes which are not required in stationary
phase cells in the absence of active glucose-based
growth [3]. Little is known regarding the metabolic
changes that occur in lag phase cells as they resume
vegetative growth following ex i tf r o ms t a t i o n a r yp h a s e .
Our data indicate that thioredoxin mutants are delayed
in lag phase, but they eventually resume exponential
phase growth following the restoration of nutrient rich
conditions. This may mean that essential enzymes are
inhibited by glutathionylation in thioredoxin mutants,
a n dt h ed e l a y e dr e s u m p t i o no fg r o w t hi sd u et ot h e
requirement to synthesize new active enzymes.
Conclusions
This study has shown that thioredoxins, and not glutar-
edoxins, are required to maintain protein glutathionyla-
tion levels during the yeast growth cycle. This is in
contrast to other eukaryotic systems where glutaredox-
ins appear to be the predominant deglutathionylase
enzymes. Our data add to the growing evidence indicat-
ing a functional overlap between the GSH/glutaredoxin
and thioredoxin systems. Redox-active proteins which
are modified by the addition of glutathione can be
reversibly regulated by the thioredoxin system, providing
a mechanism to coordinate regulation by the two major
cellular redox regulatory systems.
Methods
Yeast Strains, plasmids and growth conditions
The Saccharomyces cerevisiae strains used in this study
were isogenic derivatives of W303 (MATa ura3-52 leu2-
3 leu2-112 trp1-1 ade2-1 his3-11 can1-100). Strains
deleted for thioredoxins (trx1::TRP1 trx2::URA3), glutar-
edoxins (grx1::LEU2 grx2::HIS3) and an isogenic petite
strain have been described previously [17,18,38]. For
overexpression studies, multi-copy plasmids containing
GRX1, GLR1, TRX1 and TRR1 were constructed in pRS-
based plasmid [39].
Strains were grown in rich YEPD medium (2% w/v
glucose, 2% w/v bactopeptone, 1% w/v yeast extract) or
minimal SD medium (0.17% w/v yeast nitrogen base
without amino acids, 5% w/v ammonium sulphate, 2%
w/v glucose) supplemented with appropriate amino
acids and bases [40] at 30°C and 180 rpm. For growth
on non-fermentable carbon sources, SGE contained 3%
(v/v) glycerol and 1% (v/v) ethanol. Nitrogen (N) starva-
tion medium, contained 2% (w/v) glucose, 0.17% (w/v)
yeast nitrogen base without amino acids and limited
amounts of auxotrophic requirements (1 mg/liter for
tryptophan and 5 mg/liter for all other cases). For car-
bon (C) starvation conditions, SD medium was used
without glucose. Media were solidified by the addition
of 2% (w/v) agar.
Determination of glutathione levels
Glutathione levels were determined as described pre-
viously [41]. Briefly, cells were harvested by centrifuga-
tion, washed with phosphate-buffered saline (pH 7.4) to
remove any traces of growth medium, and resuspended
in ice-cold 8 mM HCl, 1.3% (w/v) 5-sulfosalicyclic acid.
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Page 8 of 10Cells were broken with glass beads using a Minibead
beater (Biospec Scientific, Bartlesville, OK) for 30 s at
4°C, before incubating on ice for 15 min. to precipitate
proteins. Cell debris and proteins were pelleted in a
microcentrifuge for 15 min (13,000 rpm 4°C) and the
supernatant used for the determination of free glu-
tathione. For quantification of oxidized glutathione
(GSSG), samples were pretreated with 5% (v/v) 2-vinyl-
pyridine for 1 h at room temperature before analysis.
To release protein-bound glutathione, the pellets from
the sulfosalicyclic acid extraction were resuspended in
1% sodium borohydride. To aid the release of GSH,
extracts were again shaken on a Minibead beater (20 s.,
4°C) before microfuging at 10,000 rpm for 1 h at room
temperature. The resulting supernatant was neutralized
with 100 mM potassium phosphate buffer pH 7.4 and
used to determine protein-bound GSH (GSSP). GSH
levels are expressed as nmoles of GSH per 1 A600 of
cells.
Protein purification and enzyme assays
Plasmids expressing six-histidine-residue tagged versions
of Grx1 (pBAD-YGRX1), Trx1 (pBAD-YTRX1) and
Trr1 (pBAD-YTRR1) were a kind gift from Barry Rosen
[42]. Trx2 was amplified by PCR and cloned into the
pBAD expression vector (Invitrogen). Histidine-tagged
proteins were purified by Ni
2+-NTA chromatography
and protein purity checked on SDS-PAGE gels.
GSH-dependent disulphide oxidoreductase activity was
measured by the reduction of the mixed disulfide
formed between b-hydroxyethylene disulphide (HED)
and GSH [21]. To assay Grx1, the reaction mix con-
tained NADPH (0.4 mM), GSH (1.0 mM), glutathione
reductase (6 μg/ml) and HED (1.4 mM) in 0.1 M Tris
HCl, pH 7.4. A mixed disulphide between HED and
GSH is formed within 2 min, and the reaction was
started by the addition of 17 μM Grx1. The reaction
was followed by the decrease in A340 due to the oxida-
tion of NADPH. To assay thioredoxins, Grx1 and Glr1
were substituted with Trx1 or Trx2 (1.5 μM) and Trr1
(0.5 μM), respectively. Protein disulphide reduction
activity was measured using insulin as a substrate. Reac-
tion mixtures contained insulin (0.6 mg/ml), NADPH
(0.6 mM), EDTA (1 mM), Trx1 or Trx2 (1.5 μM) and
Trr1 (0.5 μM) in 25 mM Tris HCl, pH 8.0. To assay
glutaredoxin, Trx1 or Trx2 and Trr1, were substituted
with Grx1 and Glr1 respectively. The reaction was fol-
lowed by the decrease in A340 due to the oxidation of
NADPH.
Mass spectrometry analysis
Creatine kinase and GAPDH were glutathionylated as
previously described [43]. Peptides were analysed by
matrix-assisted laser desorption ionization/time-of-flight
mass spectrometry (MALDI-TOF-MS) on a Bruker
Ultraflex II mass spectrometer. The instrument was
calibrated externally with peptide standard II from
Bruker, resulting in a mass accuracy of 100 ppm in the
range up to 5000 Da.
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